NCT05859594

Brief Summary

The research was planned as a prospective, randomized controlled experimental study to determine the effect of online laughter yoga applied to menopausal women on vasomotor symptoms (VMS) and sleep quality. Research Hypotheses ar below; H0: Online laughter yoga has no effect on VMS. H1: Online laughter yoga has an effect on VMS. H0: Online laughter yoga has no effect on sleep quality. H1: Online laughter yoga has an effect on sleep quality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 2, 2023

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

May 5, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 16, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
Last Updated

September 8, 2023

Status Verified

September 1, 2023

Enrollment Period

3 months

First QC Date

May 5, 2023

Last Update Submit

September 7, 2023

Conditions

Keywords

vasomotor symptomssleep qualitymenopauselaughter yogalaughter therapy

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scala (VAS)

    The Visual Analog Scale is used to measure the pain perceived by the person. There is a 10 cm mark on the one end of the scale, where there is no pain (zero), and on the other end there is the most severe (10) pain. Between the (100 mm.) part, the individual can indicate his or her pain by drawing a line, putting a dot or pointing. The distance from the point where there is no pain to the point marked by the individual is measured in centimeters, and the value found indicates the severity of the individual's pain. In this study, VAS will be used for hot flashes, night sweats and sweating experienced by women. Women will indicate where their situation is appropriate on this line by drawing a line or by placing a dot/mark.

    change from baseline, at the end of 4th week of intervention.

Secondary Outcomes (1)

  • Sleep quality

    change from baseline, at the end of 4th week of intervention.

Study Arms (2)

Experimental (laughter yoga) group

EXPERIMENTAL

The intervention group will receive eight online laughter yoga sessions, two sessions per week for four weeks. In this study, the number of laughter yoga sessions was determined in line with the studies in the literature. Each laughter yoga session is planned to last approximately 40-45 minutes. Each session of laughter yoga consists of clapping and warm-up exercises, deep breathing exercises, childlike play and laughter.

Other: Laughter yoga

Control group

NO INTERVENTION

The control group will receive no intervention for 4 weeks.

Interventions

Although the history of laughter yoga dates back to ancient times, its use in medicine has become widespread in the 21st century, while it is used to reduce pain, anxiety, stress, depression and fatigue, it is also a method that can be used to accelerate immunity, quality of life, happiness, sleep quality and recovery.

Also known as: Laughter therapy
Experimental (laughter yoga) group

Eligibility Criteria

Age40 Years - 60 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • \- enrolled in the Menopause School,
  • Signing the Informed Consent Form,
  • Willing to participate in the research,
  • Able to read and write Turkish,
  • Open to communication,
  • Those who are between the ages of 40-60 and have not experienced menstruation for at least one year,
  • Experiencing at least one of the vasomotor symptoms
  • A VMS severity of at least 4 according to the Visual Analog Scale,
  • Not using drugs for the treatment of vasomotor symptoms,
  • No chronic disease
  • Regular laughter yoga is not practiced,
  • Those who have not entered the menopause surgically,
  • Women without psychiatric problems

You may not qualify if:

  • \- Not enrolled in Menopause School,
  • Not signing the Informed Consent Form,
  • Not willing to participate in the research,
  • Cannot read and write Turkish,
  • Unable to communicate
  • Less than 40 years old, over 60 years old, experienced menstruation for at least one year,
  • Not experiencing vasomotor symptoms,
  • VMS severity is less than 4 according to the Visual Analog Scale,
  • Using drugs for the treatment of vasomotor symptoms,
  • Having a chronic disease,
  • Regular laughter yoga practice
  • Those who have surgically entered the menopause,
  • Women with psychiatric problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mersin University

Yenişehir, Mersin, Turkey (Türkiye)

Location

Related Links

MeSH Terms

Conditions

SyndromeSleep Initiation and Maintenance Disorders

Interventions

Laughter Therapy

Condition Hierarchy (Ancestors)

DiseasePathologic ProcessesPathological Conditions, Signs and SymptomsSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeutics

Study Officials

  • Ahu Aksoy Can, PhD

    Mersin University Nursing Faculty

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Statistical analysis of the data will be done by an expert independent of the research.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Prospective, parallel, two arm, randomized controlled clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant, PhD

Study Record Dates

First Submitted

May 5, 2023

First Posted

May 16, 2023

Study Start

May 2, 2023

Primary Completion

July 31, 2023

Study Completion

August 31, 2023

Last Updated

September 8, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations